藤黄果单独或联合西洛多辛治疗LUTS/BPH的疗效评估:前瞻性随机对照研究
该前瞻性随机双盲对照研究将LUTS/BPH患者分为三组,分别接受西洛多辛8mg每日一次、藤黄果提取物500mg每日三次或两者联合治疗12周。结果显示三组Qmax和IPSS均显著改善,联合组改善最佳;藤黄果组和联合组前列腺体积和PSA显著降低,而西洛多辛组前列腺体积显著增加。
要点
- 藤黄果提取物单用或联合西洛多辛均可显著改善LUTS/BPH患者的Qmax、IPSS和PVR。
- 联合治疗组在Qmax和IPSS改善方面表现最佳。
- 藤黄果组和联合组前列腺体积和PSA显著降低,西洛多辛组前列腺体积显著增加。
核心结论
- 藤黄果提取物尤其与西洛多辛联合使用,可能改善LUTS/BPH患者的Qmax、IPSS、PVR、PV和PSA,且无临床显著不良反应。
研究设计与样本
- 前瞻性、随机、对照、双盲研究,纳入LUTS/BPH患者,随机分为三组:A组33例接受西洛多辛8mg每日一次,B组35例接受藤黄果提取物500mg每日三次,C组36例接受两者联合,治疗12周。
主要发现
- 治疗12周后,所有组Qmax和IPSS均显著改善(P > .001),C组改善最佳。
- 所有组PVR均显著降低(P > .001)。
- A组前列腺体积显著增加(P = .006),B组和C组显著降低(P > .001)。
- A组PSA非显著增加(P = .625),B组和C组显著降低(P > .001)。
临床怎么用
- 对于LUTS/BPH患者,可考虑藤黄果提取物联合西洛多辛以改善排尿症状和生活质量。
- 藤黄果提取物可能有助于降低前列腺体积和PSA,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of Garcinia cambogia (hydroxy citric acid) alone or in combination with Silodosin on the clinical outcomes of lower urinary tract symptoms/Benign prostatic hyperplasia (LUTS/BPH). METHODS: A prospective, randomized, controlled, double-blind study conducted on patients with LUTS/BPH. Eligible patients were assigned randomly to one of three groups. Group A (33 patients) received Silodosin, 8 mg, once daily. Group B (35 patients) received Garcinia extract 500 mg TID. Group C (36 patients) received the combination of Silodosin, plus Garcinia extract. All participants were assessed for the changes in; the maximum urinary flow rate (Qmax), International Prostate Symptom Score (IPSS), Post-Void Residual (PVR), prostate volume (PV), and serum Prostatic Specific Antigen (PSA) levels, at the baseline and after 12 weeks of treatment. RESULTS: The baseline data regarding Qmax, IPSS, PVR, PV, and PSA showed non-significant differences between the three groups. After 12 weeks of treatment, all groups showed a significant improvement in both Qmax and IPSS (P >.001) and group C showed the best improvement. The PVR was significantly reduced in all groups (P >.001). The PV was significantly increased in group A (P = .006), whereas it was significantly reduced in groups B and C (P >.001). The PSA showed a non-significant increase in group A (P = .625), while it was significantly decreased in groups B and C (P >.001). CONCLUSION: Treatment with Garcinia extract, especially in combination with Silodosin, may improve the Qmax, IPSS, PVR, PV, and PSA in patients with LUTS/BPH without any clinical significant adverse effects.
引用
- El-Shaer W, Abd-Allah AR, El-Shafie MF, et al. Evaluation of the Therapeutic Potential of Garcinia cambogia Alone or in Combination With Silodosin in the Management of LUTS/BPH: A Prospective Randomized Controlled Study. Urology. 2025. PMID: 40209997. doi:10.1016/j.urology.2025.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。